Countries are at varying stages of introducing daily oral tenofovir-based PrEP, which is recommended by WHO as a prevention option for people at substantial risk of HIV. Some countries have national programs; others have smaller-scale programs; others aren’t offering PrEP at all.
In this regularly updated map, yellow countries have some form of PrEP programming; blue countries do not. Want to take the next step in expanding access to PrEP? Check out PrEP Planning A-Z.
This step-by-step framework for scaling up PrEP outlines what's involved for introducing oral PrEP and provides links to tools and resources.
The Global PrEP Tracker offers two views on PrEP uptake around the world. Visit data.prepwatch.org for a dynamic map-based tool to explore trends in oral PrEP use globally. For insights on the full scope of PrEP use around the world, the PrEP Tracker spreadsheet offers a sortable database on PrEP uptake.
As oral PrEP rolls out globally, implementers are facing and overcoming real-world obstacles. Lessons from the Field brings you these stories. Come here to learn from others, sharpen insights and find useful resources.
An analysis of global PrEP uptake, based on quarterly surveys of ongoing oral PrEP demonstration and implementation projects, and data from manufacturers and government agencies.
A long-acting antiretroviral drug given as an injection every two months powerfully protected uninfected people from HIV in a large-scale study that was disrupted by the COVID-19 pandemic.